This analysis summarizes studies comparing attained heights with expected heights of children with asthma treated with inhaled or oral corticosteroids. The possible moderating effects of treatment duration, and dosage and asthma severity are also examined.
BACKGROUND: In order to improve patient compliance, the use of charge dissipative materials in VHC construction is becoming the standard of care. A facemask is required as the interface between patient and VHC for young children who cannot breathe through a mouthpiece.
Summary: Inhaled drugs are frequently given to infants and young children with a pressurized metered-dose inhaler (pMDI) attached to a valved-holding chamber (VHC) with face mask. In young children and infants who cannot breathe through a mouthpiece, the face mask serves as the interface be
BACKGROUND: In vitro assessments of VHC performance are primarily designed to characterize aerosol formulations during product development and to ensure consistent product quality, rather than predict how the device will perform when used by a patient.
Purpose: To compare the clinical efficacy and delivery time of nebulizer of beta agonist bronchodilator with the use of the AeroElipse® Breath Actuated Nebulizer (Monaghan Medical Corp.) as compared to the Airlife Misty-Neb Nebulizer (SVN) (Allegiance Healthcare Corporation).